Інформація призначена тільки для фахівців сфери охорони здоров'я, осіб,
які мають вищу або середню спеціальну медичну освіту.


Підтвердіть, що Ви є фахівцем у сфері охорони здоров'я.

"Pain. Joints. Spine." Том 9, №2, 2019

Back to issue

Giant cell arteritis: epidemiology, diagnosis, prognosis

Authors: Нетяженко В.З. (1), Пузанова О.Г. (2)
1 - Национальный медицинский университет имени А.А. Богомольца, г. Киев, Украина
2 - Киевский медицинский университет, г. Киев, Украина

Categories: Rheumatology, Traumatology and orthopedics

Sections: Specialist manual

print version


Summary

Гігантоклітинний артеріїт (ГКА) — найпоширеніший системний васкуліт, що уражує великі судини в осіб старше 50 років. Захворювання на нього пов’язане з підвищеним ризиком розвитку низки інших запальних хвороб і судинних ускладнень. Розв’язанню основних асоційованих з ГКА проблем присвячено численні зарубіжні наукові дослідження та настанови. Метою публікації є аналітичний огляд, систематичне узагальнення та обговорення доказів, що стосуються різних аспектів епідеміології ГКА, сучасних підходів і методів його діагностики, а також чинників ризику несприятливого прогнозу.

Гигантоклеточный артериит (ГКА) — наиболее распространенный системный васкулит, поражающий крупные сосуды у лиц старше 50 лет. Заболевание сопряжено с повышенным риском развития ряда других воспалительных болезней и сосудистых осложнений. Решению основных связанных с ГКА проблем посвящено множество зарубежных научных исследований и рекомендаций. Целью публикации является аналитический обзор, систематическое обобщение и обсуждение доказательств, касающихся разных аспектов эпидемиологии ГКА, современных подходов и методов его диагностики, а также факторов риска неблагоприятного прогноза.

Giant cell arteritis (GCA) is the most common systemic vasculitis affecting large vessels in subjects over 50 years old. This di­sease is associated with an increased risk of other inflammatory disea­ses and vascular conditions. Many studies and guidelines focus on sol­ving GCA-associated problems. The aim of this paper is to perform an analytical review, systematic generalization and discussion of evidence on various epidemiological GCA aspects, modern approaches and me­thods of its diagnosis as well as risk factors of unfavorable prognosis.


Keywords

giant cell arteritis; large vessel vasculitis; epidemiology; diagnosis; prognosis

гигантоклеточный артериит; васкулит крупных сосудов; эпидемиология; диагностика; прогноз

giant cell arteritis; large vessel vasculitis; epidemiology; diagnosis; prognosis


For the full article you need to subscribe to the magazine.


Bibliography

1. Jenette J.C., Falk R.J., Bacon P.A. et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013 Jan. 65 (1). 1-11. doi: 10.1002/art.37715.
2. Dejaco C., Ramiro S., Duftner C. et al. EULAR recommendations for the use of imaging in large vessels vasculitis in clinical practice. Ann. Rheum. Dis. 2018 May. 77 (5). 636-643. doi: 10.1136/annrheumdis-2017-212649.
3. Baslund B., Helleberg M., Faurschou M., Obel N. Mortality in patients with giant cell arteritis. Rheumatology (Oxford). 2015 Jan. 54 (1). 139-143. doi: 10. 1093/rheumatology/keu303. 
4. de Boysson H., Liozon E., Lariviere D., et al. Giant cell arteritis-related stroke: a retrospective multicenter case-control study. J Rheum. 2017. 44 (3). 297-303. doi: 10. 3899/jrheum. 161033. 
5. Crow R.W., Katz B.J., Warner J.E. et al. Giant Cell Arteritis and Mortality. J. Gerontol. A Biol. Sci Med. Sci. 2009 Mar. 64 (3). 365-369. doi: 10.1093/gerona/gln030. 
6. González-Gay M.A., Pina T. Giant Cell Arteritis and Polymyalgia Rheumatica: an Update. Curr. Rheumatol. Rep. 2015 Feb. 17 (2). 6. doi: 10.1007/s11926-014-0480-1. 
7. Sigl M., Hsu E., Scheffel H., Haneder S., Rümenapf G., Amendt K. Lower extremity vasculitis in giant cell arteritis: important differential diagnosis in patient with lower limb claudication. Vasa. 2014 Sep. 43 (5). 326-336. doi: 10.1024/0301-1526/a000370. 
8. Udayakumar P.D., Crowson C.S., Warrington K.J., Matteson E.L. Incidence of giant cell arteritis in the current era of advanced diagnostic imaging. Ann. Rheum. Dis. 2013. 72 (Suppl 3). FRI0353. doi: 10.1136/annrheumdis-2013-eular.1480. 
9. Dasgupta B., Borg F.A., Hassan N. et al. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford). 2010. 49. 1594-1597. doi: 10.1093/rheumatology/keq039a. 
10. Bienvenu B., Ly K.H., Lambert M. et al. Ma–nagement of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA). Rev. Med. Intern. 2016. 37 (3). 154-165. doi: 10.1016/j.revmed.2015.12.015. 
11. Beketova T.V., Satybaldyev A.M., Denisov L.N. International guidelines for the management of giant cell arteritis and polymyalgia rheumatica: The 2015 results. Nauchno-prakticheskaya revmatologiya. 2016. 54 (4). 390-394. doi: 10.14412/1995-4484-2016-390-394. 
12. Buttgereit F., Dejaco C., Matteson E.L., Dasgupta B. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review. JAMA. 2016 Jun. 315 (22). 2442-2458. doi: 10.1001/jama.2016.5444. 
13. Guevara M., Kollipara C.S. Recent Advances in Giant Cell Arteritis. Curr. Rheumatol. Rep. 2018 Apr 2. 20 (5). 25. doi: 10.1007/s11926-018-0737-1. 
14. Kermani T.A., Schäfer V.S., Crowson C.S. et al. Increase in age at onset of giant cell arteritis: a population-based study. Ann. Rheum. Dis. 2010 Apr. 69 (4). 780-781. doi: 10.1136/ard.2009.111005. 
15. Koster M.J., Matteson E.L., Warrington K.J. Large-vessel giant cell arteritis: diagnosis, monitoring and mana–gement. Rheumatology. 2018. 57. ii32-ii42. doi: 10.1093/rheumatology.kex424. 
16. Levine S.M., Hellmann D.B. Giant cell arteritis. Curr. Opin Rheumatol. 2002 Jan. 14 (1). 3-10. 
17. Nesher G., Breuer S.G. Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update. Rambam Maimonides Med. 2016. 7 (4). e0035. doi: 10.5041/RMMJ.10262. 
18. Ness T., Bley T.A., Schmidt W.A., Lamprecht P. The Diagnosis and Treatment of Giant Cell Arteritis. Dtsch Arztebl Int. 2013 May. 110 (21). 376-386. doi: 10.3238/arztebl.2013.0376. 
19. Watanabe R., Hilhorst M., Zhang H. et al. Glucose metabolism controls disease-specific signatures of macrophage effector functions. JCI Insight. 2018 Oct 18. 3 (20). pii: 123047. doi: 10.1172/jci.insight.123047. 
20. Laviriere D., Sacre K., Klein I. et al. Extra- and intracranial cerebral vasculitis in giant cell arteritis: an observational study. Medicine (Baltimore). 2014 Dec. 93 (28). e265. doi: 10.1097/MD.0000000000000265. 
21. Chen J.J., Leavitt J.A., Fang C. et al. Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell Arteritis. Ophthalmology. 2016 Sep. 123 (9). 1999-2003. doi: 10.1016/j.ophtha.2016.05.008. 
22. Machado E.B., Michet C.J., Ballard D.J. et al. Trends in incidence and clinical presentations of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum. 1988 Jun. 31 (6). 745-749. 
23. Nuenninghoff D.M., Hunder G.G., Christianson T.J., McClelland R.L., Matteson E.L. Mortality of large-artery complications (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003 Dec. 48 (12). 3532-7. doi: 10.1002/art.11480. 
24. Machado E.B., Gabriel S.E., Beard C.M., Michet C.J., O’Fallon W.M., Ballard D.J. A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease? Int. J. Epidemiol. 1989 Dec. 18 (4). 836-841. doi: 10.1093/ije/18.4.836. 
25. Crowson C.S., Matteson E.L., Myasoedova E. et al. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011 Mar. 63 (3). 633-639. doi: 10.1002/art.30155. 
26. Stellingwerff M.D., Brouwer E., Lensen K.J. et al. Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis: Need for Standardization. Medicine (Baltimore). 2015 Sep. 94 (37). e1542. doi: 10.1097/MD.0000000000001542. 
27. Genda E., Oyoo O., Adebajo A. Vasculitis in Africa. Curr. Rheumatol. Rep. 2018 Feb 21. 20 (2). 4. doi: 10.1007/s11926-018-0711-y. 
28. Watts R.A., Scott D.G. Epidemiology of vasculitis. In: Ball G.V., Fessler B.J., Bridges S.L., eds. Oxford textbook of vasculitis. 3rd ed. Oxford: Oxford University Press, 2014. 7-28 p. doi: 10.1093/med/9780199659869.003.0002. 
29. Nuenninghoff D.M., Hunder G.G., Christianson T.J., McClelland R.L., Matteson E.L. Incidence and Predictors of Large-Artery Complication (Aortic Aneurysm, Aortic Dissection, and/or Large-Artery Stenosis) in Patients with Giant Cell Arteritis: A Population-Based Study Over 50 Years. Arthritis Rheum. 2003 Dec. 48 (12). 3522-31. doi: org/10.1002/art.11353. 
30. Hellmich B. Management der Polymyalgia rheumatica und der Großgefäßvaskulitiden. Internist (Berl). 2016 Nov. 57 (11). 1069-1078. doi: 10.1007/s00108-016-0131-x. 
31. Petri H., Nevitt A., Saesour K., Napalkov P., Collinson N. Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities. Arthritis Care Res. (Hoboken). 2015 Mar. 67 (3). 390-395. doi: 10.1002/acr.22429. 
32. Lensen K.D., Voskuyl A.E., van der Laken C.S. et al. 18F-fluorodeoxyglucose positron emission tomography in elderly patients with elevated erythrocyte sedimentation rate of unknown origin. PloS One. 2013. 8 (3). e58917. doi: 10.1371./journal.pone.0058917. 
33. Hill C.L., Black R.J., Nossent J.C. et al. Risk of mortality in patients with giant cell arteritis. Semin. Arthritis Rheum. 2017. 46 (4). 513-519. doi: 10.1016/j.semarthrit. 2016.08.015. 
34. Evans J.M., O’Fallon W.M., Hunder G.G. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann. Intern. Med. 1995 Apr 1. 122 (7). 502-7. 
35. Mackie S.L., Hensor E.M., Morgan A.W., Pease C.T. Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis. Ann. Rheum. Dis. 2014. 73 (1). 143-148. doi: 10.1136/annrheumdis-2012-202145. 
36. Robson J.C., Kiran A., Maskell J. et al. The relative risk of aortic aneurysm in patient with giant cell arteritis compared with the general population of the UK. Ann. Rheum. Dis. 2015. 74 (1). 129-135. doi: 10.1136/annrheumdis-2013-204113. 
37. Kermani T.A., Warrington K.J., Crowson C.S. et al. Large Vessel Involvement in Giant Cell Arteritis: A Population-Based Cohort Study of the Incidence-Trends and Prognosis. Ann. Rheum. Dis. 2013. 72 (12). 1989-1994. doi: 10.1136/annrheumdis-2012-202408. 
38. Matteson E.L., Buttgereit F., Dejaco C., Dasgupta B. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis. Rheum. Dis. Clin. North Am. 2016 Feb. 42 (1). 75-90, viii. doi: 10. 1016/j.rdc.2015.08.009. 
39. Laviriere D., Benali K., Coustet B. et al. Positron emission tomography and computed tomography for the diagnosis of giant cell arteritis. A real-life prospective study. Medicine (Baltimore). 2016 Jul. 95 (30). e4146. doi: 10.1097/MD.0000000000004146. 
40. Alsolaimani R.S., Bhavsar S.V., Khalidi N.A. et al. Severe intracranial involvement in giant cell arteritis: 5 cases and literature review. J. Rheumatol. 2016 Mar. 43 (3). 648-656. doi: 10.3899/jrheum.150143. 
41. Ungprasert P., Wijampreecha K., Koster M.J., Thongprayoon C., Warrington K.J. Cerebrovascular accident in patients with giant cell arteritis: A systematic review and meta-analysis of cohort studies. Semin. Arthritis Rheum. 2016 Dec. 46 (3). 361-366. doi: 10.1016/j.semarthrit.2016.07.005. 
42. Ungprasert P., Koster M.J., Warrington K.J. Coronary artery disease in giant cell arteritis: a systematic review and meta-analysis. Semin. Arthritis Rheum. 2015. 44 (5). 586-591. doi: 10.1016/j.semarthrit.2014.10.010. 
43. Ungprasert P., Thongprayoon C., Kittonamingkolchai W., Srivali N., Cheungpasitporn W. Peripheral arterial disease in patients with giant cell arteritis: a meta-analysis. Int. J. Rheum. Dis. 2016 Aug. 19 (8). 819-825. doi: 10.1111/1756-185X.12631. 
44. Ungprasert P., Sanguankeo A., Upala S., Knight E.L. Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis. Semin. Arthritis Rheum. 2014 Dec. 44 (3). 366-370. doi: 10.1016/j.semarthrit.2014.06.004. 
45. Ungprasert P., Upala S., Sanguankeo A., Warrington K.J. Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: a systematic review and meta-analysis. Mod. Rheumatol. 2016. 26 (3). 410-414. doi: 10.3109/14397595.2015.1081722. 
46. Li L., Neogi T., Jick S. Giant cell arteritis and vascular diseases — risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink. Rheumatology (Oxford). 2017 May. 56 (5). 753-762. doi: 10.1093/rheumatology/kew482. 
47. Hunder G.G., Bloch D.A., Michel B.A. et al. The American College of Rheumatology 1990 criteria for classification of giant cell arteritis. Arthritis Rheum. 1990 Aug. 33 (8). 1122-1128. doi: 10.1002/art.1780330810. 
48. Lie J.T. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histological documentation. Semin. Arthritis Rheum. 1995. 24 (6). 422-431. 
49. Brack A., Martinez-Taboada V., Stanson A., Goronzy J.J., Weyand C.M. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum. 1999 Feb. 42 (2). 311-317. doi: https.//doi.org/10.1002/1529-0131(199902)42. 2<311.AID-ANR14>3.0.CO.2-F
50. Muratore F., Kermani T.A., Crowson C.S. et al. Large-vessel giant cell arteritis: a cohort study. Rheumato–logy (Oxford). 2015. 54 (3). 463-470. doi: 10/1093/rheumatology/keu329. 
51. Smetana G.W., Shmerling R.H. Does this patient have temporal arteritis? JAMA. 2002. 287 (1). 92-101. doi: 10.1001/jama.287.1.92. 
52. Ghinoi A., Pipitone N., Nicolini A. et al. Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour-Doppler sonography study. Rheumatology (Oxford). 2012 Apr. 51 (4). 730-734. doi: 10.1093/rheumatology/ker329. 
53. Bongartz T., Matteson E.L. Large vessel involvement in giant cell arteritis. Curr. Opin. Rheumatol. 2006. 18 (1). 10-17. 
54. Maksimovicz-McKinnon K., Clark T.M., Hoffmann G.S. Takayasu arteritis and giant cell arteritis: a spectrum within the same disease? Medicine (Baltimore). 2009. 88 (4). 221-226. doi: 10.1097/MD.0b013e3181af70c1. 
55. Schmidt W.A., Seifert A., Gromnica-Ihle E., Krause A., Natusch A. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford). 2008. 47 (1). 96-101. doi: 10.1093/rheumatology/kem322. 
56. Weyand C.M., Goronzy J.J. Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N. Engl. J. Med. 2014. 371 (1). 50-57. doi: 10.1056/NEJMcp1214825. 
57. Cavazza A., Muratore F., Boiardi L. et al. Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations. Am. J. Surg. Pathol. 2014 Oct. 38 (10). 1360-1370. doi: 10. 1097/PAS. 0000000000000244. 
58. Kermani T.A., Matteson E.L., Hunder G.G., Warrington K.J. Symptomatic Lower Extremity Vasculitis in Giant Cell Arteritis: a Case Series. J. Rheumatol. 2009 Oct. 36 (10). 2277-2283. doi: 10.3899/rheum.090269. 
59. Alba M.A., Garcia-Martinez A., Prieto-Gonzáles S. et al. Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients. Medicine (Baltimore). 2014 Jul. 93 (5). 194-201. doi: 10.1097/MD.0000000000000033. 
60. Restuccia G., Boiardi L., Cavazza A. et al. Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Cha–racteristics and Predictors in a Long-Term Follow-Up Study. Medicine (Baltimore). 2016 May. 95 (19). e3524. doi: 10. 1097/MD. 0000000000003524. 
61. Restuccia G., Boiardi L., Cavazza A. et al. Long-term remission in biopsy-proven giant cell arteritis: a retrospective cohort study. J. Autoimmun. 2017 Feb. 77. 39-44. doi: 10.1016/j.jaut.2016.10.002. 
62. Martinez-Lado L., Calviño-Diaz C., Piñeiro A. et al. Relapses and recurrenceses in giant cell arteritis: a population-based study of patients with biopsy-proven disease from northwestern Spain. Medicine (Baltimore). 2011 May. 90 (3). 186-193. doi: 10.1097/MD.0b013e31821c4fad. 
63. Labarca С., Koster M.J., Crowson C.S. et al. Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study. Rheumatology (Oxford). 2016 Feb. 55 (2). 347-356. doi: 10.1093/rheumatology/kev348. 
64. Kermani T.A., Crowson C.S., Muratore F., Schmidt J., Matteson E.L., Warrington K.J. Extra-cranial giant cell arteritis and Takayasu arteritis: How similar are they? Semin. Arthritis Rheum. 2015. 44 (6). 724-728. doi: 10.1016/jseminarthrit.2015.01.005. 
65. Schmidt W.A. Role of ultrasound in the understan–ding and management of vasculitis. Ther. Adv. Musculoskelet. Dis. 2014. 6 (2). 39-47. doi: 10.1177/1759720X13512256. 
66. Koster M.J., Warrington K.J. Classification of large vessel vasculitis. Can we separate giant cell arteritis from Takayasu arteritis? Presse Med. 2017 Jul — Aug. 46 (7-8 Pt 2). e205-e213. doi: 10.1016/j.lpm.2016.11.032. 
67. Futura S., Cousins C., Chaudhry A. Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity? J. Rheumatol. 2015. 42 (2). 300-308. doi: 10.3899/jrheum.140562. 
68. Blockmans D., de Ceuninck D.L., Vanderschüren S., Knockärt D., Mortelmans L., Bobbärs H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum. 2006. 55 (1). 131-137. doi: 10.1002/art.21699. 
69. Agard C., Barrier J.H., Dupas B. et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic compu–ted tomodensitometric scan. Arthritis Rheum. 2008. 59 (5). 670-676. doi: 10.1002/art.23577. 
70. Prieto-González S., Arguis P., Garsia-Martinez A. et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann. Rheum. Dis. 2012. 71 (7). 1170-1176. doi: 10.1136/annrheumdis-2011-200865. 
71. Prieto-González S., Depetris M., Garsia-Martinez A. et al. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed biopsy-proven giant cell arteritis: a prospective, case-control study. Ann. Rheum. Dis. 2014. 73 (7). 1388-1392. doi: 10.1136/annrheumdis-2013-204572. 
72. García-Martínez A., Hernández-Rodríguez J., Arguis P. et al. Development of aortic aneurysm / dilatation during the follow-up of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum. 2008. 59 (3). 422-430. doi: 10.1002/art.23315. 
73. Mekinian A., Djelbani S., Viry F., Fain O., Soussan M. Usefulness of imaging in large vessel vasculitis. Rev. Med. Interne. 2016. 37 (4). 245-255. doi: 10.1016/j.revmed.2015.10.353. 
74. Lensen K.D., Voskuyl A.E., Comans E.F., van der Laken C.J., Smulders Y.M. Extracranial giant cell arteritis: A narrative review. Neth. J. Med. 2016. 74 (5). 182-192. 
75. Schmidt J., Duhaut P. Aortitis in giant cell arteritis. Rev. Med. Interne. 2016. 37 (4). 239-244. doi: 10.1016/j.revmed.2015.12.018. 
76. Lee Y.H., Choi S.J., Ji J.D., Song G.G. Diagnostic accuracy of 18F-FDG PET or PET/CT for large vessel vasculitis: A meta-analysis. Z. Rheumatol. 2016. 75 (9). 924-931. doi: 10.1007/s00393-015-1674-2. 
77. Besson F.L., Parienti J.J., Bienvenu B. Diagnostic perfomance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur. J. Nucl. Med. 2011. 38 (9). 1764-1772. doi: 10.1007/s00259-011-1830-0. 
78. Soussan M., Nicolas P., Schramm C. et al. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis. Medicine (Baltimore). 2015. 94. e622. doi: 10.1097/MD.0000000000000622. 
79. Schmidt W.A., Moll A., Seifert A., Schicke B., Gromnica-Ihle E., Krause A. Prognosis of large-vessel giant cell arteritis. Rheumatology (Oxford). 2008. 47 (9). 1406-1408. doi: 10.1093/rheumatology/ken258. 
80. Diamantopulos A.P., Haugeberg G., Hetland H., Soldal D.M., Bie R., Myklebust G. Diagnostic value of colour Doppler ultrasonography of temporal arteries and large vessels in giant cell arteritis: a consecutive case series. Arthritis Care Res. (Hoboken). 2014. 66 (1). 113-119. doi: 10.1002/acr.22178. 
81. Prieto-González S., Terrades-Garsia N., Corbera-Bellalta M. et al. Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with gigant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients. RMD Open. 2017 Dec. 3 (2). e000570. doi: 10.1136/rdmopen-2017-000570. 
82. Prieto-González S., Garsia-Martinez A., Tavera-Bahillo I. et al. Effect of glucocorticoid treatment on computer tomography angiography detected large vessel inflammation in giant cell arteritis. A prospective, longitudinal study. Medicine (Baltimore). 2015 Feb. 94 (5): e486. doi: 10.1097/MD.0000000000000486.

Similar articles

Gastrointestinal manifestations of systemic vasculitis: a spectrum of clinical manifestations, diagnosis and treatment
Authors: Головач И.Ю.(1), Егудина Е.Д.(2)
(1) — Клиническая больница «Феофания» Государственного управления делами, г. Киев, Украина
(2) — Клиника современной ревматологии, г. Киев, Украина

"Gastroenterology" Том 53, №4, 2019
Date: 2019.11.21
Categories: Gastroenterology
Sections: Specialist manual
Case report of atypical course of mpo-anca associated vasculitis
Authors: Boyarchuk O.R., Smiyan S.I. - I.Horbachevsky Ternopil State Medical University, Ukraine
"Child`s Health" 8 (59) 2014
Date: 2015.03.03
Categories: Pediatrics/Neonatology
Sections: Specialist manual
Features of renal involvement in systemic connective tissue diseases
Authors: Головач И.Ю.(1), Егудина Е.Д.(2)
(1) — Клиническая больница «Феофания» Государственного управления делами, г. Киев, Украина
(2) — ГУ «Днепропетровская государственная медицинская академия МЗ Украины», г. Днепр, Украина

"Kidneys" Том 7, №4, 2018
Date: 2018.12.12
Categories: Nephrology
Sections: Specialist manual
Arthritis in primary immunodeficiencies
Authors: Боярчук О.Р., Волянська Л.А., Ковальчук Т.А., Кінаш М.І.
ДВНЗ «Тернопільський державний медичний університет імені І.Я. Горбачевського МОЗ України», м. Тернопіль, Україна

"Pain. Joints. Spine." Том 7, №1, 2017
Date: 2017.06.21
Categories: Rheumatology, Traumatology and orthopedics
Sections: Specialist manual

Back to issue